Barclays analyst Jonathon Unwin upgraded Schott Pharma AG (1SXP:GR) from Equalweight to Overweight with a price target of EUR27.00 (from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE